The differential CYP1A1 and CYP1B1 expressions in normal tissues and tumour tissues may provide an opportunity for the development of tumour-selective drugs for the effective treatment of a variety of different cancers [32,37]. This evidence concerns the gene CYP1B1 and cancer.